Newsroom

Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.

Ogimi in Okinawa, Japan has the highest percentage of centenarians in the world, making it a curiosity for those eager to learn more about the secrets of aging.

Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.

Novartis innovation and events such as mHealth Challenge enable patients to access data and personal information about their health via mobile devices.

A global survey revealed major disconnects in communication, disease awareness and expectations between patients and physicians.

Talk to any cancer researcher or doctor today and what you hear is wonder and hope.

Cambridge neighbors, NIBR and Harvard, further disrupt technology. Read how their alliance is accelerating drug discovery.

The majority of Europeans can’t identify the warning signs of heart failure, a life threatening disease, which affects one in five people in the region.

Novartis researchers use automation to rapidly identify starting points for new drugs.